India Glycols Ltd
INDIAGLYCOIndia Glycols Ltd
INDIAGLYCO
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 22.23 | 2.10 | 0.57% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 30.03 | 3.41 | 1.36% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
India Glycols Limited is a company engaged in the manufacturing of technology-based bulk, specialty and performance chemicals, natural gums, spirits, industrial gases, sugar and nutraceuticals.
Peers
Compare with peersSolar Industries India Ltd
Linde India Ltd
Deepak Nitrite Ltd
Himadri Speciality Chemical Ltd
Sumitomo Chemical India Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,334.85 | 2,507.01 | 3,057.44 | 3,373.51 | 2,784.03 | 2,355.38 | 3,570.55 | 2,714.26 | 3,336.36 | 3,807.85 | ||||||||||
Raw Materials | 1,505.44 | 1,486.25 | 1,830.87 | 1,913.88 | 1,673.94 | 1,354.14 | 1,811.50 | 1,338.44 | 1,797.24 | 3,312.02 | ||||||||||
| Power & Fuel Cost | 301.60 | 288.99 | 335.55 | 410.41 | 250.34 | 213.93 | 332.08 | 417.47 | 328.44 | |||||||||||
| Employee Cost | 88.37 | 96.04 | 97.06 | 100.84 | 93.28 | 83.33 | 89.16 | 88.80 | 103.37 | |||||||||||
| Selling & Administrative Expenses | 185.56 | 177.52 | 173.28 | 186.90 | 128.32 | 130.65 | 156.06 | 113.95 | 146.54 | |||||||||||
| Operating & Other expenses | 126.34 | 214.50 | 275.28 | 328.64 | 311.18 | 266.94 | 652.52 | 396.67 | 516.03 | |||||||||||
EBITDA | 127.54 | 243.71 | 345.40 | 432.84 | 326.97 | 306.39 | 529.23 | 358.93 | 444.74 | 495.83 | ||||||||||
| Depreciation/Amortization | 69.48 | 72.04 | 73.10 | 76.24 | 77.53 | 80.12 | 80.29 | 93.96 | 100.77 | 107.42 | ||||||||||
| PBIT | 58.06 | 171.67 | 272.30 | 356.60 | 249.44 | 226.27 | 448.94 | 264.97 | 343.97 | 388.41 | ||||||||||
| Interest & Other Items | 139.24 | 126.68 | 125.14 | 143.48 | 96.90 | 83.38 | 69.66 | 99.96 | 120.67 | 139.81 | ||||||||||
| PBT | -81.18 | 44.99 | 147.16 | 213.12 | 152.54 | 142.89 | 379.28 | 165.01 | 223.30 | 248.60 | ||||||||||
| Taxes & Other Items | -24.36 | 9.95 | 50.63 | 80.51 | 37.87 | 11.28 | 39.43 | 39.92 | 50.32 | 54.67 | ||||||||||
| Net Income | -56.82 | 35.04 | 96.53 | 132.61 | 114.67 | 131.61 | 339.85 | 125.09 | 172.98 | 193.93 | ||||||||||
| EPS | -18.35 | 11.32 | 31.18 | 42.83 | 37.04 | 42.51 | 109.77 | 40.40 | 55.87 | 62.64 | ||||||||||
| DPS | 0.00 | 1.00 | 4.00 | 6.00 | 6.00 | 6.00 | 7.50 | 7.50 | 8.00 | 8.00 | ||||||||||
| Payout ratio | 0.00 | 0.09 | 0.13 | 0.14 | 0.16 | 0.14 | 0.07 | 0.19 | 0.14 | 0.13 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| India Glycols Ltd | 24.92 | 2.10 | 0.57% |
| Solar Industries India Ltd | 111.74 | 27.26 | 0.08% |
| Linde India Ltd | 129.00 | 16.15 | 0.18% |
| Deepak Nitrite Ltd | 44.29 | 7.45 | 0.28% |
Price Comparison
Compare INDIAGLYCO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.15%
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 1.86%
Top 5 Mutual Funds holding India Glycols Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
JM Flexicap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1622% | Percentage of the fund’s portfolio invested in the stock 0.99% | Change in the portfolio weight of the stock over the last 3 months -0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 62/79 (-5) |
JM Value Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3293% | Percentage of the fund’s portfolio invested in the stock 1.31% | Change in the portfolio weight of the stock over the last 3 months -0.24% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 53/76 (-4) |
JM Small Cap Fund - Direct Plan - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1951% | Percentage of the fund’s portfolio invested in the stock 1.36% | Change in the portfolio weight of the stock over the last 3 months -0.46% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 60/86 (-11) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
INDIAGLYCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.57%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.75 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 21, 2024
Dividend/Share
₹8.00
Ex DateEx Date
Aug 21, 2024
Cash Dividend
Ex DateEx DateSep 5, 2023
Dividend/Share
₹7.50
Ex DateEx Date
Sep 5, 2023
Cash Dividend
Ex DateEx DateAug 29, 2022
Dividend/Share
₹7.50
Ex DateEx Date
Aug 29, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Dividend/Share
₹6.00
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateMar 11, 2020
Dividend/Share
₹6.00
Ex DateEx Date
Mar 11, 2020
The company will initially subscribe to 10,000 equity shares at face value of Rs 10 each aggregating to Rs 1,00,000 in cash. The company will carry on business of spirits and related products. India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB). The company's consolidated net profit jumped 30.8% on 24.1% increase in revenue from operations to Rs 961.20 crore in Q2 FY25 over Q2 FY24. The counter rallied 3.29% to end at Rs 1196.85 on Tuesday, 26 November 2024. Powered by Capital Market - Live
India Glycols has incorporated 'IGL Spirits' as its wholly owned subsidiary Company on 25 November 2024. Powered by Capital Market - Live
Net profit of India Glycols rose 30.78% to Rs 49.71 crore in the quarter ended September 2024 as against Rs 38.01 crore during the previous quarter ended September 2023. Sales rose 24.09% to Rs 961.20 crore in the quarter ended September 2024 as against Rs 774.60 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales961.20774.60 24 OPM %12.0512.33 - PBDT91.0378.06 17 PBT63.4650.10 27 NP49.7138.01 31 Powered by Capital Market - Live
India Glycols will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live
India Glycols will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live
The Board of India Glycols at its meeting held on 21 September 2024 has approved appointment of Sushil Dutt Salwan (DIN: 10776621) and Samrat Banerjee (DIN: 06706345) as Additional Directors in the category of independent directors of the Company with effect from 01 October 2024. The Board also noted the cessation of Pradip Kumar Khaitan (DIN: 00004821), Jagmohan N. Kejriwal (DIN: 00074012), Ravi Jhunjhunwala (DIN: 00060972), and Jitender Balakrishnan (DIN: 00028320) as Independent Directors of the Company upon the completion of their second term, with effect from the close of business hours on 30 September 2024. Powered by Capital Market - Live
India Glycols has tied up with Amrut Distilleries, Bengaluru, for manufacturing, bottling, marketing and selling of Amrut's few premium brands on royalty basis. The Board at its meeting held on 21 September 2024 has noted the same. Powered by Capital Market - Live
India Glycols announced that CARE Ratings has revised the ratings on bank facilities of the company as under: Fund based LT bank guarantee (Rs 72.63 crore) - CARE A-; Stable (reaffirmed) Fund based LT term loan (Rs 1405.31 crore) - CARE A-; Stable (reaffirmed) Fund based LT / ST working capital limits (Rs 450 crore) - CARE A-; Stable/ CARE A2+ (revised from CARE A-; Stable) Non fund based ST BG/ LC (Rs 846.98 crore) - CARE A2+ (reaffirmed)Powered by Capital Market - Live
The agency has also affirmed the company's short term rating at 'CARE A2+'. CARE Ratings stated that the ratings continue to take comfort from company's diversified revenue streams, which mitigate volatility impact in one segment and healthy market position in bio-based glycols, potable spirit (PS), and nutraceutical segment, leading to large scale of operations. The company has also significantly scaled up its biofuel business over the recent couple of fiscals as well. These rating strengths are partially tempered by its improving yet moderate operating profitability which is vulnerable to volatility in input costs and company's moderately leveraged capital structure and average debt coverage metrics. The company's capital expenditure program is largely completed and is expected to focus on generating significant cashflows from the same and strengthen its coverage ratio, particularly, net debt (including LC acceptances) to PBILDT below 4.5x by FY25 end. Also, the PS business is highly regulated by government. Factors like improvement in debt coverage metrics and sustenance of significant liquidity buffers built up from cash and cash equivalents could lead to a ratings upgrade. However, reduction in diversification of business risk profile and incremental debt programmes or deterioration of profitability could lead to ratings downgrade. India Glycols (IGL) manufactures green technology-based bulk, specialty, and performance chemicals and natural gums, spirits, industrial gases, sugar, and nutraceuticals. It operates under three broad segments: Bio-based specialities & Performance Chemicals (BSPC), Biofuels, potable spirit (PS), and ennature biopharma (EB). The scrip shed 0.19% to currently trade at Rs 1217.65 on the BSE. Powered by Capital Market - Live
India Glycols announced that the 40th Annual General Meeting (AGM) of the company will be held on 28 August 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -0.22%, vs industry avg of 9.38%
Decreasing Market Share
Over the last 5 years, market share decreased from 4.63% to 2.87%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 5.46%, vs industry avg of 4.33%